Chronic Hemodialysis

Healio has compiled a list of the most-read nephrology-related exclusive features in 2024.

A topical cream containing cannabis “significantly reduced the severity of itching” symptoms in patients with chronic kidney disease-related pruritus, according to published data.

Lower dialysate sodium concentrations may be “independently associated” with higher mortality in patients on hemodialysis, according to a multinational retrospective study.

The FDA has approved DefenCath, a catheter lock solution of taurolidine and heparin by CorMedix Inc., for adults with kidney failure on chronic hemodialysis, according to a press release.

AstraZeneca has been granted fast track designation in the U.S. for the development of Lokelma, according to a company press release.

The oral anemia drug daprodustat showed noninferiority to erythropoiesis-stimulating agents for achieving targeted hemoglobin levels and cardiovascular risk in patients with kidney disease on dialysis and not on dialysis, according to phase 3 data presented at ASN Kidney Week.

In the past several years, patients’ experience of care has garnered significant attention within hospitals and health systems and is now increasing in importance and visibility within the dialysis community.